enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Subscribe to see enVVeno Medical Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
enVVeno Medical Corporation is a medical devices company headquartered in Irvine, United States. It is publicly listed (NVNO) with a market capitalisation of $5.7M. Xcout tracks 11 named people at enVVeno Medical Corporation, including Robert A. Berman (Chief Executive Officer & Director).
5 more named people on record for enVVeno Medical Corporation, with roles, board committees and tenure — see the full roster →
A few of enVVeno Medical Corporation's closest competitors — see the full list of competitors and alternatives →
Venova Medical Inc. is a clinical-stage medical device company headquartered in Los Gatos, California. Founded in 2018, the firm focuses on addressing challenges associated with providing optimal vascular access for patients requiring hemodialysis. The privately held company develops specialized vascular technologies to improve patient care outcomes.
VVT Med Inc. develops minimally invasive, catheter-based medical devices designed for the treatment of various venous pathologies, including varicose veins. The company's proprietary products, such as ScleroSafe and V-Block, utilize mechanochemical technology to provide precise, non-thermal, and in-office vein closure treatments for patients.
Innova Vascular, Inc. is a medical device company based in Irvine, California, engaged in the development of innovative minimally invasive vascular technologies such as the Laguna Thrombectomy System.
InterVene, Inc. is a medical device company headquartered in Redwood City, California, dedicated to developing innovative technologies for treating venous diseases and related complications.
InVera Medical is a medical device company based in the medtech cluster of Galway, Ireland. The company focuses on developing next-generation, less invasive treatment solutions for patients suffering from chronic venous disease.
JenaValve Technology, Inc. is a medical equipment manufacturing company headquartered in Irvine, California. The company specializes in developing advanced heart valves and medical solutions designed to treat conditions such as aortic regurgitation.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.